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The nonstructural proteins of parvovirus exert a variety of disparate functions during viral infection ranging from promoter
regulation, involvement in DNA replication, and induction of apoptosis. Our interest was focused on the possible mechanism
by which the NS1 protein mediates its effects on the p6 promoter of parvovirus B19. It is known that the p6 promoter is highly
active in different cell lines and interaction with the viral NS1 protein results in a further increase of the activity. The protein
may function by binding directly to the viral DNA or via an indirect binding through interaction with cellular transcription
factors bound to the promoter. We examined the interaction of the NS1 protein with cellular transcription factors which are
involved in regulating the promoter activity. After purified baculovirus-expressed NS1 protein in gel retardation assays was
added, an altered complex formation was observed, indicating that NS1 protein interacts with Sp1/Sp3 transcription factors.
Enzyme-linked immunosorbent assays verified these findings. The direct interaction of NS1 protein with p6 promoter
elements was analyzed by a coprecipitation assay whereby labeled oligonucleotides spanning the entire promoter region
were incubated with NS1 protein followed by an immunoprecipitation with NS1-specific antibodies. An eight-nucleotide-long,
almost palindromic sequence (AGGGCGGA) was found as potential NS1-binding motif. Footprint analysis with oligonucleo-
tides containing this DNA motif confirmed this result. Thus, transcriptional regulation by the NS1 protein may involve bothion andINTRODUCTION
Parvovirus B19, the only member of the Parvoviridae
that is pathogenic in humans, is a small nonenveloped
icosahedral virus with a single-stranded linear 5.6-kb
DNA genome. Both ends of the DNA genome are iden-
tical inverted terminal repeats (ITR) of 383 nucleotides in
length. The distal 365 nucleotides of these repeats are
imperfect palindromes that form hairpin structures which
are necessary for priming DNA replication. The only
functionally active promoter within the viral genome, the
p6 promoter, is located at the 5 palindrome and regu-
lates the synthesis of all nine viral transcripts (Blundell et
al., 1987; Doerig et al., 1990). Seven of these are mRNAs
and are used for synthesis of a multifunctional protein,
the so-called nonstructural protein 1 (NS1), two capsid
proteins (VP1 and VP2), and several smaller polypeptides
with still unknown function (Cotmore and Tattersall, 1984;
Luo and Astell, 1993; Ozawa et al., 1987).
The NS1 protein of parvovirus B19 is a multifunctional
protein that performs many different functions during the
virus life cycle. Besides trans-regulation of the p6 pro-
moter, NS1 proteins influence the activity of other viral
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86and cellular promoters (Doerig et al., 1990; Sol et al.,
1993; Moffatt et al., 1996; Liu et al., 1991; Momoeda et al.,
1994; Gareus et al., 1998). ATPase and DNA helicase
activity have been predicted based on homology studies
with proteins of other autonomous animal parvoviruses
(Doerig et al., 1990). Further enzymatic reactions during
viral DNA replication were intensively studied for minute
virus of mice supposed to be the initiation of replication
by site-specific nicking within the origin of replication,
generating free 3 hydroxyls, which serve as primers for
the DNA polymerase (Cotmore and Tattersall, 1994;
Christensen et al., 1997; Cotmore and Tattersall, 1998).
The strong cytopathic effect of parvovirus B19 leading
to apoptosis in erythroid cells seems to be caused by an
interaction between the NS1 protein and tumor necrosis
factor  pathways (Sol et al., 1999).
The mechanism by which the NS1 protein of B19
exerts its transcriptional regulation has not been inves-
tigated. The viral protein can interact either directly with
specific promoter sequences or indirectly via interaction
with DNA-binding proteins. We previously analyzed cel-
lular transcription factors which are involved in the reg-
ulation of the promoter activity (Raab et al., 2001). Based
on these studies we investigated the interaction of the
NS1 protein with cellular transcription factors using pu-the interaction with Sp1/Sp3 that binds to the promoter reg
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rified baculovirus-expressed NS1 protein in gel retarda-
tion assays and ELISA. The direct interaction of NS1 with
p6 promoter elements was analyzed by incubating 32P-
labeled oligonucleotides spanning the entire promoter
region with NS1 proteins followed by coimmunprecipita-
tion with NS1-specific antibodies. Our results indicate
that the NS1 proteins interact with the p6 promoter by
binding to cellular transcription factors and by direct
DNA binding. Both mechanisms may influence viral gene
expression and promoter activity as well as genome
replication and DNA synthesis.
RESULTS
Interaction between the viral NS1 protein and the
transcription factors Sp1/Sp3
To analyze how the multifunctional NS1 protein of
parvovirus B19 mediates its strong activity to trans-
activate the p6 promoter, electrophoretic mobility shift
assays (EMSA) using baculovirus-expressed NS1-pro-
tein were performed. As published previously, the in-
teractions of DNA-binding proteins of different nuclear
cell extracts with three p6 promoter regions were
characterized in detail (Raab et al., 2001). Thus we
could demonstrate binding of the transcription factor
Sp1 to three GC boxes within the p6 promoter and
specific interaction of the factor Sp3 preferentially to
two of these GC motifs in the direct vicinity of the TATA
box. After addition of purified NS1 protein produced by
recombinant baculovirus into samples containing oli-
gonucleotides of all three promoter regions and nu-
clear extracts from HeLa cells, the DNA–protein com-
plexes were analyzed by gel retardation assays. A
change in complex formation was observed exclu-
sively for the oligonucleotide spanning region H. The
two major and two minor retarded bands identified as
complexes formed of Sp1 and Sp3 factors were almost
totally inhibited in the presence of NS1 protein (Fig.
1A, region H), revealing that the viral protein influ-
ences the binding of both transcription factors to the
DNA fragments. Interestingly, we observed that the
formation of the Sp1/DNA complex with region D is not
altered by the presence of NS1 protein. Controls using
the Sp1 consensus sequence in the retardation as-
says confirmed that the NS1 protein interacts with the
transcription factors Sp1 and Sp3, both of which are
involved in the formation of the major retarded bands
because the formation of both DNA–protein com-
plexes was inhibited. These results indicate that the
NS1 protein interferes exclusively with the binding of
Sp1 and Sp3 to the GC boxes present in promoter
region H. The binding of Sp1 to the GC box in region
D was not altered.
To validate complex formation between NS1 and Sp1/
Sp3 proteins, an enzyme-linked immunosorbent assay
(ELISA) was performed using NS1 protein bound to the
solid phase and HA-tagged Sp1 or Sp3, both produced
with recombinant baculovirus as potential binding part-
ners. Comparison of the expression levels of Sp1 and
Sp3 by Western blot analysis revealed that nearly iden-
tical amounts of protein were produced (data not shown).
Monoclonal antibodies directed against the HA tag fused
to factors Sp1 and Sp3, and peroxidase-conjugated sec-
ondary antibodies were used to detect the bound tran-
scription factors. As a control, Sf9 cell extracts infected
with wild-type baculovirus were applied. The results
demonstrate that both transcription factors Sp1 and Sp3
bind specifically and with similar affinity to NS1 protein
and thus confirm the data obtained by EMSA (Fig. 1B).
Background values observed for the control using crude
extracts of Sf9 cells infected with wild-type baculovirus
were negligible (less than 0.01).
FIG. 1. NS1 protein interacting with the transcription factors Sp1 and
Sp3. (A) NS1 inhibits the binding of cellular transcription factors Sp1/
Sp3 to region H of the p6 promoter. EMSAs were performed using
32P-labeled oligonucleotides (region D, region H, and Sp consensus
sequence), 5 g of nuclear extracts prepared from HeLa cells, and 1.25
g of baculovirus-expressed NS1 protein as indicated. After electro-
phoresis, the gels were exposed to X-ray films. The assignments of the
transcription factors that were identified as parts of the complexes are
given. (B) Purified baculovirus-expressed NS1 protein immobilized on
ELISA plates was incubated for 1.5 h with crude extracts of Sf9 cells
expressing HA-tagged SP1 or Sp3. After washing, bound transcription
factors were detected by a monoclonal anti-HA antibody followed by
peroxidase-conjugated second antibody. Bound Sp1 or Sp3 was quan-
titated spectrophotometrically. Control wells were incubated with crude
extracts of Sf9 cell infected with wild-type baculovirus (control).
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NS1 protein binds to an 8-nt sequence element within
the p6 promoter
To examine whether the NS1 protein interacts di-
rectly with p6 promoter elements, an approach similar
to that used to demonstrate the direct binding of the
NS1 protein of MVM to the p38 promoter was used
(Cotmore et al., 1995). The eight oligonucleotides
spanning the entire promoter region (see Fig. 2A) were
labeled with [-32P]ATP and incubated with NS1 pro-
tein. The protein–DNA complexes were immunopre-
cipitated with NS1-specific human monoclonal anti-
bodies (Gigler et al., 1999). Oligonucleotides spanning
regions A and D were precipitated efficiently and spe-
cifically. A third NS1–DNA complex (region F) was
immunoprecipitated, however, to a lesser extent (Fig.
2B).
After the sequences represented by oligonucleo-
tides A, D, and F were analyzed, a common sequence
element, an almost palindromic octamer motif 5-
AGGGCGGA-3 could be identified in region A, whereas
regions D and F contained the complementary sequence
5-TCCCGCCT-3.
To determine if the NS1 protein interacts with this
octamer, we used short oligonucleotides (14 nt) contain-
ing the potential NS1-binding motif, the mutated form of
the binding motif with 3 nucleotide exchanges in the
center of the motif, and an oligonucleotide (21 nt) com-
prising the Sp1 consensus sequence into the immuno-
precipitation assay. In this analysis, the DNA fragment
with the NS1-binding motif was exclusively precipitated
and complex formation with the mutated oligonucleotide
or the Sp1 consensus sequence was not observed (Fig.
2C). The specificity of NS1 binding to the octamer motif
was examined by competitive inhibition using a DNA
binding assay with 32P-labeled oligonucleotides of region
A together with the NS1 motif or the mutated fragment
(NS1-mut) as competitor oligonucleotides. Binding could
be inhibited by a 50-fold excess of the NS1 motif as
competitor (data not shown). These results confirm the
sequence specificity of the interaction and suggest that
NS1 proteins recognize this motif even if it is present in
a short DNA fragment.
NS1 proteins protect oligonucleotides from digestion
with DNase I
DNase I protection assays were carried out using an
oligonucleotide of 77 nt of length comprising region A
and partly region B and purified preparations of NS1
protein. These assays showed a footprint of 55 bp
present in both DNA strands (Fig. 3). The DNA sequence
protected by NS1 proteins extends from the nucleotide at
position 9 up to the nucleotide at position 65. Because
this represents a relatively large region, it may be as-
sumed that NS1 proteins exert their DNA-binding activity
in an oligomeric form. Furthermore, the footprint is rather
asymmetric with respect to the potential NS1-binding
site. It extends 14 nucleotides 5 to the NS1 motif and 33
nucleotides into the 3 direction. These results confirm
our previous observations that NS1 protein binds directly
to the promoter DNA.
Helicase activity of NS1 proteins
Preparations of recombinant NS1 proteins produced in
S2 cells were analyzed for potential helicase activity. The
helicase assay used a [-32P]ATP-labeled oligonucleo-
tide annealed to single-stranded M13mp18 DNA as sub-
strate.
The advantage of the S2 expression system is that the
recombinant NS1 protein is secreted into serum-free
medium. Therefore, the protein could be applied into the
helicase assays after concentration without a further
purification step that may destroy the structure of the
protein and the enzyme activity. As shown in Fig. 4 (lanes
2, 3, 4) NS1 protein is able to displace the labeled
oligonucleotides as part of the double-stranded sub-
strate. The level of activity to unwind DNA fragments
from a circular M13 template increased with increasing
amount of NS1 protein up to 900 ng.
DISCUSSION
We have demonstrated two mechanisms by which the
NS1 protein of parvovirus B19 may influence the activity
of the p6 promoter: It binds directly to the p6 promoter
through the DNA sequence element which contains an
almost palindromic motif AGGGCGGA, and it binds indi-
rectly via interaction with the cellular transcription fac-
tors Sp1/Sp3. Based on previous studies where we iden-
tified various transcription factors binding to the pro-
moter of parvovirus B19 using electrophoretic mobility
shift assays, we have now analyzed the interactions of
the viral NS1 protein with the complexes formed by the
promoter DNA and the cellular transcription factors.
These results suggest that the interaction is mediated
via binding of the NS1 protein to the transcription factors
Sp1 and Sp3. The observation that NS1 protein interacts
with the factors Sp1/Sp3 is supported by previous data
indicating that the transactivation mediated by the viral
protein was significantly reduced by the introduction of
mutations into the GC boxes used as binding sites for
Sp1/Sp3 proteins (Gareus et al., 1998). Interestingly, the
NS1 protein seems to interact preferentially with Sp1
proteins bound to the GC boxes located in region H, the
only region where factor Sp3 could be identified as an
interaction partner. In region D containing one GC box,
binding of Sp3 proteins was not observed and NS1-
proteins did not influence the complex formation. It may
be speculated that the protein interactions depend on
individual flanking sequences that are necessary for the
formation of the Sp1/Sp3–NS1 protein complexes with
the promoter or that the presence of Sp3 is indispens-
88 RAAB ET AL.
able. An alternative explanation is that NS1 proteins
interact with complexes of at least two Sp1/Sp3 mole-
cules, indicating that the assembly to oligomers may
facilitate the interaction of NS1 proteins with these tran-
scription factors. A supershifted band containing Sp1/
Sp3 and NS1 proteins cannot, as yet, be demonstrated.
This may be because EMSA is not the appropriate sys-
tem for the resolution of multicomponent complexes. Sp1
proteins are ubiquitously synthesized and stimulate the
transcription activity of a variety of cellular and viral
promoters (Lania et al., 1997). In competition with Sp1,
binding of the factor Sp3 can repress or activate gene
expression as it has been shown for several human and
viral genes (Hagen et al., 1994; Kwon et al., 1999; Qin et
al., 1999; Tsai et al., 1999). Our ELISA data allow specu-
lation that binding of NS1 proteins to Sp1/Sp3 occurs
independently of binding to viral DNA. Therefore, the
overexpression of the NS1 gene that has been observed
in cells nonpermissive for parvovirus B19 infection could
result in a deregulation of the compatibility of Sp1/Sp3 in
regulation of critical cellular promoter. Similar to our
experiments for parvovirus B19, interaction of the NS1
protein of MVM (minute virus of mice) with factor Sp1 has
been demonstrated by DNA affinity chromatography and
FIG. 2. NS1 binding to regions A and D of the p6 promoter. (A)
Sequence of the p6 promoter of parvovirus B19 subdivided into eight
regions (A–H). The overlapping nucleotide sequences of the eight
oligonucleotides used for the protein–DNA immunoprecipitation are
marked by bold letters. The potential NS1-binding motif is marked by
red boxes. (B) Immunprecipitation assays were performed using 32P-
labeled oligos (regions A–H) incubated with 500 ng of purified bacu-
lovirus-expressed NS1 protein and precipitated with a monoclonal
anti-NS1 antibody or with a monoclonal anti-VP1 antibody (control).
Samples were deproteinized by incubation with proteinase K and
subsequently analyzed on an agarose gel. After electrophoresis the
gels were exposed to X-ray films. (C) NS1 binding to NS1 motif
AGGCGGGA. Autoradiography of an agarose gel showing a immuno-
precipitation with the 32P-labeled oligonucleotides (NS1 motif, NS1 mut,
Sp1 cons) treated as described above. BSA was used as control protein. FIG. 3. NS1 protects a 56-bp fragment within region A of the p6
promoter. DNase I protection analysis (left, lower strand; right, upper
strand) was performed with different amounts of purified NS1 (lane 1,
0.25 g; 2, 0.5 g; 3, 2.5 g; 4, 3.75 g; 5, 5 g; 6, 5 g control protein)
in the presence of  S-ATP and 1 U of DNase I. At the left and right side
of the footprint the sequence of the protected region is shown. The
potential NS1-binding site is marked by boxed area.
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immunoprecipitation experiments (Krady and Ward,
1995).
Until now, direct binding of NS1 proteins to DNA ele-
ments in the p6 promoter could not be shown for parvo-
virus B19. With respect to the NS1 protein of MVM it has
been suggested that rather unstable complexes of NS1
protein and DNA may form in the presence of ATP. Due
to the rapid dissociation of the complex, it was impossi-
ble to directly demonstrate the interaction of NS1 pro-
teins with DNA by standard gel shift assays. The binding
of NS1 protein to the transactivation region of the p38
promoter of MVM was finally shown by using a DNA–
protein binding assay (Christensen et al., 1995). Based
on a similar approach, we were able to identify a NS1-
binding octamer motif (Fig. 2B). An alternative approach
using biotinylated oligonucleotides containing the NS1
motif or NS1 mut on a streptavidin-coated matrix that
was incubated with NS1 protein and subsequently with
NS1-specific antibodies confirmed the coprecipitation
results (data not shown). Competition assays using a
50-fold excess of unlabeled oligonucleotides with NS1
motif inhibited the precipitation and therefore could verify
the specificity of NS1 binding (data not shown). The
octamer motif AGGGCGGA is present in the left- and in
the right-hand hairpin regions of the viral genome (nt 39
to nt 46 and nt 5080 to nt 5088; referring to plasmid
pYT103 (Shade et al., 1986) and two times in a comple-
mentary form TCCCGCCT at positions nt 148 to nt 155
and 216 to nt 223. In contrast to our results, the site
binding the NS1 protein of MVM is distributed at regular
intervals throughout the entire MVM genome, suggesting
that the binding of NS1 proteins may additionally play a
structural role in the formation of viral chromatin in the
infected cells. A further significant difference is that NS1
proteins of MVM only bind its recognition site when it is
present in the context of flanking DNA sequences and
inhibition of the binding can only be achieved when the
appropriate oligonucleotide is ligated into a fragment of
more than 21 nt (Christensen et al., 1995).
During parvovirus replication, two steps exist that re-
quire DNA unwinding activity. The first is during terminal
resolution when the DNA polymerase is copying the
sequences of the terminal repeat. The second event
occurs during the next step in genome replication when
the terminal palindrome has to be unwound to reform the
terminal hairpin for the displacement of the priming
strand. NS1 protein exhibits ATP-dependent helicase ac-
tivity. It was striking that in the helicase and all other
described assays we had to use 5- to 10-fold amounts of
protein to show any protein function compared to the
published data of other parvoviral nonstructural proteins
(Wilson et al., 1991; Christensen et al., 1995; Im and
Muzyczka, 1990). This may be due to the rapid degrada-
tion and the high instability of NS1 proteins independent
of expression either via recombinant baculovirus or in S2
cells.
NS1 proteins of MVM form oligomers and mutations in
ATP-binding fold prevent the self-association, indicating
that ATP binding may induce the formation of multimers
that facilitate binding to viral DNA (Pujol et al., 1997;
Nuesch and Tattersall, 1993). The poor binding of NS1
proteins of MVM to the promoter in the absence of ATP
can be increased 10-fold by addition of ATP. For the NS1
protein of parvovirus B19 we cannot demonstrate such a
strong dependence on ATP, although the binding of the
protein to the NS1 motif is impaired slightly in the ab-
sence of ATP (data not shown). Similar to the NS1 protein
of the B19 virus, the nonstructural proteins Rep 68 and
Rep 78 of helper-dependent parvoviruses AAV 2 bind to
their respective recognition sites in the absence of ATP
(McCarty et al., 1994; Owens et al., 1991). Nevertheless,
the large size of the NS1 footprint and the failure to
demonstrate the binding of the NS1 protein of parvovirus
B19 to DNA in EMSAs indicate the formation of NS1
oligomers in our system.
At present, relatively few details about the proteins
associated with replicating DNA of parvovirus B19 in vivo
are known due to the lack of an appropriate cell culture
system. Furthermore, it is not clear if indirect binding of
the NS1-proteins to Sp1/Sp3 oligomers or the direct
interaction with the viral DNA is the primary step for gene
expression and which one is the potentiating mechanism
of transactivation. On the basis of our results, both reg-
ulatory elements appear to be required for efficient trans-
activation of the p6 promoter.
MATERIALS AND METHODS
Oligonucleotides
The oligonucleotides containing the consensus bind-
ing site for Sp1/Sp3 and the respective nonspecific oli-
FIG. 4. NS1 protein expressed in D2 cells exhibits DNA helicase
activity. M13 primer helicase substrate (see Materials and Methods)
was incubated without NS1-protein (lane 1) or 300 ng (lane 2), 600 ng
(lane 3), or 900 ng (lane 4) of NS1 protein for 30 min at 37°C. Lane 5
shows unreacted helicase substrate boiled prior to electrophoresis.
The reaction mixtures were analyzed on 10% nondenaturing acrylamide
gels.
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gonucleotide were obtained from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA) and were ready for use. The double-
stranded probes were radioactively labeled by the use of
T4 polynucleotide kinase and [-32P]ATP (5000 Ci/mmol;
Amersham) to a specific activity of 100 cpm/g and
subsequently purified by chromatography (Micro Bio-
Spin 6, Bio-Rad, Munich, FRG). The sequences of the
eight oligonucleotides used in NS1-DNA binding assays
have been published elsewhere (Raab et al., 2001).
Antibodies
Monoclonal antibodies specific for Sp1 and Sp3 were
obtained from Santa Cruz Biotechnology. Monoclonal
antibodies directed to viral NS1 and VP1 proteins have
been described elsewhere (Gigler et al., 1999). The
monoclonal anti-HA antibody was obtained by Roche
Diagnostics (Mannheim, Germany).
Purification of recombinant NS1 protein
Recombinant baculovirus encoding the NS1 gene was
used to infect Sf9 cells at a multiplicity of infection of 2.
Infected cells (1  109) were harvested 4 days postin-
fection and lysed in the presence of protease inhibitors
(0.1 mM phenylmethylsulfonyl fluoride, 2 g/ml pepstatin,
and 2 g/ml leupeptin) by the addition of phosphate-
buffered saline–0.5% (w/v) sodium deoxycholate. After
centrifugation (3000 g for 5 min), the insoluble fraction
containing recombinant NS1 protein and nuclei was re-
suspended in 25 mM HEPES, 5 mM MgSO4, pH 7.4, and
subjected to DNase treatment (final concentration: 10
g/ml) (Sigma, Poole, UK) for 1 h at room temperature.
Following a brief centrifugation and wash step (3000 g, 3
min), the insoluble NS1 protein was resuspended in
0.5–1.0 ml 6 M guanidinium thiocyanate at a concentra-
tion of 4–5 mg/ml. This preparation was diluted to 0.5
mg/ml in 50 mM NaHCO3, pH 9.4, containing 8 M urea
and dialyzed against 50 mM NaHCO3, pH 9.4, to remove
denaturing agents prior to binding assay.
Cloning of the NS1 gene into pMT/BIP/V5-His
PCR was used to amplify the NS1 coding sequence
from pJB by using the primers 5-ATTAGAATTCCCCATG-
GAGCTATTTAGAGGG-3 and 5-ATTAAGATCTGTCGACT-
TACTCATAATCTACAAAGC-3) (Mori et al., 1987) creating
two restriction sites, EcoRI and SalI. The resulting 2-kb
fragment was digested with EcoRI and SalI and cloned
into the EcoRI and SalI sites of the pSVK3 vector. Sub-
sequently, the NS1-coding region was subcloned as an
EcoRI–SalI restriction fragment into the expression plas-
mid pMT/BiP/V5/His (Invitrogen, Groningen, Nether-
lands) using the EcoRI and XhoI sites.
NS1 gene expression in S2 cells
S2 cells were maintained and induced to produce
recombinant NS1 protein according to manufacturers’
instructions (Invitrogen). S2 cells (kindly provided by Dr.
Gabler, University of Regensburg) were maintained at
24°C in DES Expression Medium (Invitrogen), supple-
mented with 10% fetal calf serum. Cells were cotrans-
fected with 1 g of pCoHygro (Invitrogen), encoding the
gene for hygromycin resistance and 19 g of pMT-NS1
using the CaPO4 precipitation method. Five days post-
transfection, hygromycin was added to a final concen-
tration of 300 g/ml. Cells were passaged approximately
every 4–5 days. A stable population of hygromycin-resis-
tant cells was obtained after 4 weeks. S2 cells were
induced to produce NS1 proteins by addition of 500 M
CuSO4.
Nuclear extracts
Preparation of the nuclear extracts was performed as
previously described (Raab et al., 2001). Briefly, 1  109
HeLa cells/ml were washed twice in PBS and once in
hypotonic buffer (10 mM HEPES (pH 7.9), 10 mM KCl, 1.5
mM MgCl2). The cells were resuspended in 1 vol of
hypotonic buffer and incubated for 10 min on ice. The
suspension was transferred into a dounce homogenizer
and cells were lysed by a minimal number of strokes
(20–30) until most of the cells were broken. Nuclei
were recovered by centrifugation (5 min, 750 g), sus-
pended in 1 ml of hypotonic buffer, and collected by
centrifugation. The nuclei were suspended in one vol-
ume (100–300 l) of high-salt extraction buffer (20 mM
HEPES (pH 7.9), 25% glycerol, 0.6 M KCl, 1.5 mM MgCl2,
0.2 mM EDTA) and incubated for 30 min at 4°C with
gentle rocking. Following this incubation, the mixture
was centrifuged (30 min, 100,000 g). The supernatant
was dialyzed at 4°C for 3 h (10 mM HEPES (pH 7.9), 10%
glycerol, 100 mM NaCl, 1 mM EDTA). The protein con-
centration in the extracts was determined as 2 g/l.
Electrophoretic mobility shift assays (EMSAs)
Gel retardation assays were performed using 5 g
nuclear extracts of HeLa cells, 1 g poly(dI-dC), and 20
fmol labeled DNA in a final volume of 20 l containing 8
l of the binding buffer (100 mM Tris/HCl, pH 7.5, 500 mM
NaCl, 5 mM dithiothreitol), 5 mM MgCl2, 10% glycerol,
0,05% NP40. For shift assays in the presence of NS1
protein 2 l of binding buffer containing 3 mM MgCl2
was added. For controls, nonradiolabeled competitor oli-
gonucleotides were added to the reaction prior to the
addition of labeled DNA probes. The samples were sub-
jected to electrophoresis on native 5% polyacrylamide
gels (37.5:1 acrylamide:bisacrylamide) containing 0.5
TBE. Gels were subsequently dried for autoradiography.
NS1 protein/DNA-binding assay
Binding assays were performed as described else-
where (Cotmore et al., 1995). Briefly, approximately 800
ng of purified baculovirus-expressed NS1 protein was
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incubated for 10 min in a final volume of 100 l binding
buffer B (20 mM Tris/HCl, pH 7.5, 125 mM NaCl, 10%
glycerol, 1% NP40, 5 mM dithiothreitol, 200 ng poly(dI-
dC), 0.5 mM ATP) before 1.5 pmol of 32P-labeled oligonu-
cleotides was added. Samples were incubated for an-
other 30 min on ice before 2 l of antibody was added
and the incubation continued for an hour. Binding buffer
(30 l) containing 1.5 mg of swollen protein A–Sepharose
beads was added and the mixture were gently shaken
and left overnight at 4°C. After removal of the superna-
tant, immunoprecipitates were washed three times with
1 ml binding buffer. Samples were deproteinized by in-
cubation with proteinase K in the presence of 0.5% SDS
for 1 h at 55°C before analysis by electrophoresis on
2.5% agarose gels. Gels were dried and exposed for
autoradiography.
DNase I protection analysis
Footprinting was performed as described (Niller and





CGACCGGCGGCATC-3 were end-labeled with T4
polynucleotide kinase and [-32P]ATP. After end-labeling,
either labeled strand was hybridized with its unlabeled
counterpart. For footprinting, protein was incubated with
0.1 g of poly(dI-dC) at room temperature (RT) for 10 min
followed by an incubation of 15 min with 8 ng of end-
labeled fragments (20,000 cpm) in 12 mM HEPES/KOH,
pH 7.9, 10% glycerol, 1.6 mM dithiothreitol, 0.12 mM EDTA,
60 mM KCl, and 6 mM MgCl2 in a reaction volume of 50
l. -S-ATP was included as indicated. The probe was
digested with 1 unit of DNase I (RNase free, Roche) at RT
for 1 min. The DNase I digestion was stopped by addition
of 100 l of stop solution (100 mM Tris/HCl, pH 7.5, 100
mM NaCl, 10 mM EDTA, 1% SDS, 10 g proteinase K, 1
g tRNA), incubation for 15 min at 37°C, and denatur-
ation at 90°C for 2 min. Digestion products were phenol
extracted, ethanol precipitated, and separated on a 6%
sequencing gel. Maxam and Gilbert AG sequencing
markers (Maxam and Gilbert, 1980) of the corresponding
probes were used to locate the footprints.
Helicase assay
A 17-base oligonucleotide (universal primer, Amer-
sham Pharmacia Biotech, Freiburg, Germany) was radio-
actively labeled with [-32P]dATP by the use of T4 polynu-
cleotide kinase at 37°C for 1 h. Unincorporated ATP was
removed by chromatography (Micro Bio-Spin 6, Bio-Rad,
Munich, FRG). Subsequently, the radioactively labeled
oligos were annealed to 1 g of single-stranded
M13mp18 DNA (Amersham). The DNA helicase assay
was performed in a reaction mixture of 30 l containing
5 l of “one-phor-all”-buffer (10 mM Tris–acetate, pH 7.5,
10 mM Mg acetate, 50 mM K-acetate, 1 mM ATP, 4 mM
DTE), 20 ng of substrate, and indicated amounts of pro-
tein. The reaction was incubated for 30 min at 37°C and
stopped by addition of gel-loading buffer. Products of the
reaction were analyzed on an 8% polyacrylamide gel in
1 TBE. Following electrophoresis, gels were dried and
autoradiographed.
ELISA
Purified NS1 protein produced by recombinant bacu-
lovirus was diluted to a final concentration of 2 g/ml in
10 mM Na2CO3, 30 mM NaHCO3, pH 9.6. One hundred
microliters of the solution was incubated per well of
ELISA plates (4°C, overnight). The wells were washed
three times with PBS, 0.05% Tween, and blocked with
PBS containing 2% BSA at RT for 1 h and washed three
times with PBS, 0,05% Tween. HA-tagged Sp1 produced
by recombinant baculovirus (kindly provided by Dr.
Horowitz, North Carolina State University) was added
into the wells (crude Sf9 cell extracts of 104 infected
cells/well), incubated for 1.5 h at 37°C, and washed three
times. After incubation with 100 l of anti-HA rat mono-
clonal antibodies (1.5 h at 37°C, dilution 1:1000), the
wells were washed followed by an incubation with 100 l
of 1:1000 diluted horseradish peroxidase-conjugated
rabbit anti-rat antibody (1.5 h at 37°C). After washing, 100
l of TMB reagent substrate (BD Pharmingen, Heidel-
berg, Germany) was added and incubated for 15 min.
H2SO4 (2 N) was added and the optical density was
determined at 450 nm.
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